CHARM评分:预测疑似脓毒症患者死亡风险的简易实用评分开发与验证
本研究为实用队列研究,纳入2010至2012年某三级教学医院连续急诊成人患者(有感染诊断编码且医生开具两套血培养),推导队列7011例、验证队列12110例,院内死亡分别为479例(7%)和1145例(9%)。独立死亡预测因素为无寒战(OR 2.28,95%CI 1.75-2.97)、低体温(OR 2.12,95%CI 1.57-2.85)、贫血(OR 2.45,95%CI 1.97-3.04)、RDW增宽(OR 3.27,95%CI 2.63-4.05)和恶性肿瘤史(OR 2.00,95%CI 1.63-2.46)。CHARM评分对死亡风险分层表现良好(敏感度99.4%,阴性预测值99.7%,ROC曲线下面积0.77),且优于PIRO、SIRS、MEDS、CURB-65、C反应蛋白、降钙素原和乳酸(均p<.05)。
要点
- CHARM评分由5项组成:无寒战、低体温、贫血、RDW增宽、恶性肿瘤史,用于急诊疑似脓毒症患者早期死亡风险分层。
- 推导队列7011例中死亡479例(7%),验证队列12110例中死亡1145例(9%)。
- CHARM评分敏感度99.4%,阴性预测值99.7%,ROC曲线下面积0.77。
- CHARM评分优于PIRO、SIRS、MEDS、CURB-65、C反应蛋白、降钙素原和乳酸(均p<.05)。
适用人群与场景
- 急诊科连续成人患者(年龄18岁或以上),有记录的感染诊断编码,且医生开具两套血培养,2010至2012年某三级教学医院。
研究设计与关键结果
- 研究类型为实用队列研究,推导队列7011例,验证队列12110例,院内死亡分别为479例(7%)和1145例(9%)。
- 独立死亡预测因素:无寒战(OR 2.28,95%CI 1.75-2.97)、低体温(OR 2.12,95%CI 1.57-2.85)、贫血(OR 2.45,95%CI 1.97-3.04)、RDW增宽(OR 3.27,95%CI 2.63-4.05)、恶性肿瘤史(OR 2.00,95%CI 1.63-2.46)。
- CHARM评分对死亡风险分层表现良好:敏感度99.4%,阴性预测值99.7%,ROC曲线下面积0.77。
- CHARM评分优于PIRO、SIRS、MEDS、CURB-65、C反应蛋白、降钙素原和乳酸(均p<.05)。
证据类型、等级与局限
- 证据类型:实用队列研究(推导与验证)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,该简易实用模型可用于疑似脓毒症患者早期阶段的死亡风险分层。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: We aimed to derive and validate a parsimonious and pragmatic clinical prediction rule using the concepts of Predisposition, Infection, Response, and Organ Dysfunction to predict in-hospital mortality; and to compare it with other prediction rules, as well as with conventional biomarkers for evaluating the mortality risk of patients with suspected sepsis in the emergency department (ED).
METHODS: We conducted a pragmatic cohort study with consecutive ED patients aged 18 or older with documented diagnostic codes of infection and two sets of blood culture ordered by physicians between 2010 and 2012 in a tertiary teaching hospital.
RESULTS: 7011 and 12,110 patients were included in the derivation cohort and the validation cohort for the final analysis. There were 479 deaths (7%) in the derivation cohort and 1145 deaths (9%) in the validation cohort. Independent predictors of death were absence of Chills (odds ratio: 2.28, 95% confidence interval: 1.75-2.97), Hypothermia (2.12, 1.57-2.85), Anemia (2.45, 1.97-3.04), wide Red cell Distribution Width (RDW) (3.27, 2.63-4.05) and history of Malignancy (2.00, 1.63-2.46). This novel clinical prediction rule (CHARM) performed well for stratifying patients into mortality risk groups (sensitivity: 99.4%, negative predictive value 99.7%, receiver operating characteristic area 0.77). The CHARM score also outperformed the other scores or biomarkers such as PIRO, SIRS, MEDS, CURB-65, C-reactive protein, procalcitonin and lactate (all p<.05).
CONCLUSIONS: In patients with suspected sepsis, this parsimonious and pragmatic model could be utilized to stratify the mortality risk of patients in the early stage of sepsis.
参考来源
- Chen KF, Liu SH, Li CH, et al. Development and validation of a parsimonious and pragmatic CHARM score to predict mortality in patients with suspected sepsis. Am J Emerg Med. 2016. PMID: 27832977. doi:10.1016/j.ajem.2016.10.075
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。